Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 8/2007

01-08-2007 | Case Report

Mononeuritis multiplex as a presenting feature of Wegener granulomatosis: a case report

Authors: R. Peshin, D. O’Gradaigh

Published in: Clinical Rheumatology | Issue 8/2007

Login to get access

Abstract

We report the case of a man presenting with clinical features of a mononeuritis multiplex, a perinuclear-ANCA (p-ANCA), and a renal biopsy suggestive of Wegener granulomatosis (WG). We wish to highlight this case as a learning point for clinicians as WG rarely presents in this form, and can be easily overlooked as a cause of mononeuritis multiplex.
Literature
1.
2.
Sturzenegger M, Stratmann A, Wyss P (1993) Mononeuritis multiplex as initial manifestation of systemic granulomatosis. Nervenartz 64(4)250–257 April
3.
Azevedo Filho H, Correia C, Lins O, Coutinho O, de Almeida P, Vidal CH (2001) Vasculitic neuropathy in Wegeners Granulomatosis: case report. Arq NeuroPsiquiatr 59(2-A):270–271PubMed
4.
de Groot K, Schmidt DK, Arlt AC, Gross WL, Reinhold-Keller E (2001) Standardized neurologic evaluation of 128 patients with Wegeners granulomatosis. Arch Neurol 58(8):1215–1221PubMedCrossRef
5.
Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE (1993) Neurological involvement in Wegeners granulomatosis. An analysis of 324 consecutive patients at the Mayo clinic. Ann Neurol 33(1):4–9PubMedCrossRef
6.
Blockmans D, Stevens E, Marien G, Bobbaers H (1998) Clinical spectrum associated with positive ANCA titres in 94 consecutive patients: is there a relation with PR-3 negative c-ANCA and hypergammaglobulinemia? Ann Rheum Dis 57(3):141–145PubMedCrossRef
7.
Gross WL, Schmitt WH, Csernok E (1991) Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist’s perspective. Am J Kidney Dis 18:175–179PubMed
8.
Vizjak A, Rott T, Koselj-Katjna M, Rozman B, Kaplan-Pavlovic S, Ferluga D (2003) Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis 41(3):539–549 MarPubMedCrossRef
Metadata
Title
Mononeuritis multiplex as a presenting feature of Wegener granulomatosis: a case report
Authors
R. Peshin
D. O’Gradaigh
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 8/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0413-0

Other articles of this Issue 8/2007

Clinical Rheumatology 8/2007 Go to the issue

Case Report

Successful treatment of life-threatening intestinal ulcer in Behçet’s disease with infliximab: rapid healing of Behçet’s ulcer with infliximab

Original Article

Brazilian-Portuguese version of the Health Assessment Questionnaire for Spondyloarthropathies (HAQ-S) in patients with ankylosing spondylitis: a translation, cross-cultural adaptation, and validation

Original Article

Peripheral neuropathy in Behçet disease: an electroneurophysiological study

Case Report

Low-dose intra-venous cyclophosphamide therapy in a patient with neurological complications of Behçet’s disease

Case Report

An extensive vertebral hydatidosis revealed by a lumbosciatica

Original Article

Analgesic activity of a polysaccharide in experimental osteoarthritis in rats
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits